Beyond the finish line - Dr Andrew Rut in PharmaTimes
COVID-19 Therapeutics and Vaccines Are Here: What All Companies Need to Do Next
Should I stay or should I go? How can pharma help drive COVID-19 vaccination adherence?
Listen Now! Trust, verify, and disclose the expected and known side effects for the new coronavirus vaccines before the mass vaccination programs begin.
Aurinia Pharmaceuticals selects Reportum QuickStart to streamline drug safety reporting
Drug safety should be top-of-mind during COVID-19 developments - Dr. Andrew Rut in PharmaTimes
Drug Safety During the COVID-19 Pandemic - Dr. Andrew Rut in Pharmaceutical Executive
Coronavirus (COVID-19) Statement
For expert insight and updates from the MyMeds&Me team.
We respect your privacy and we will only use your email address for newsletters and company updates
To find out more or request a demo fill in the details below: